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Abstract: This report documents a case of T cell lymphoma manifesting only with a 
conjunctival mass. A 67-year-old man underwent a diagnostic punch biopsy, histopathological 
examination, and immunohistochemical study for a pink-yellow colored mass infiltrating the 
bulbar conjunctiva in the lower fornix of the eyelid. A biopsy specimen of the conjunctival 
mass was found histopathologically to be a malignant T cell lymphoma. Systemic involvement 
was diagnosed within four weeks after the initial diagnosis by computed tomography, showing 
evidence of extension at the level of the ethmoidal cells, optic nerve, periorbital tissue, and 
pancreas. T cell lymphoma of the conjunctiva as a primary manifestation of systemic cancer 
is an uncommon entity. Punch biopsy may be the first diagnostic pathway useful to initiate a 
search for systemic involvement of a malignant lymphoid tumor of T cell lineage.
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Introduction
Lymphoid neoplasms of the conjunctiva may appear as an isolated tumor or as part 
of systemic disease.1–5 Generally, conjunctival lymphoma presents as a mass lesion 
on the superficial ocular surface. These lymphomas are classically described as 
“salmon-colored patches”, and may present bilaterally in up to 20% of patients.4,5 
Lesions have a fleshy appearance and may develop rapidly. Often they appear to 
arise from within the fornix and extend towards the cornea. B cell lymphoma is the 
most common type of conjunctival lymphoma, whereas the T cell form is very rare.2–5 
In this report, we document the clinical and histopathological findings in a patient 
with conjunctival lymphoma that was the first presentation of systemic malignant 
lymphomatous T cell proliferation.
Case report
On March 15, 2006, a 67-year-old male patient came to our attention complaining of 
pain and hyperemia in his left eye. His medical history was significant for weight loss in 
the last previous two months. His visual acuity was 20/80 in both eyes. Anterior segment 
slit-lamp biomicroscopy of the left eye showed a pink-yellow colored mass infiltrating the 
bulbar conjunctiva in the lower fornix of the eyelid and a corneal ulcer at the 9 o’clock 
position with perilimbal congestion and chemosis (Figure 1A and B). Funduscopy was 
normal. The right eye did not show any abnormality. The left eye was treated with topical 
steroid/antibiotic medication with an ocular bandage for one week.
A control visit showed disappearance of corneal ulcer, and a diagnostic punch 
biopsy of the conjunctival mass was taken for immunohistochemical examination. 
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The conjunctiva was infiltrated by a diffuse proliferation of 
small- to medium-sized lymphoid cells which were partly 
necrotic. The lymphoid population showed nuclear atypia, 
vesicular nuclei, and prominent nucleoli. Focal efface-
ment of the serous glands of the conjunctiva was observed 
(Figure 2). The neoplastic cells were homogeneously CD3+, 
CD5-, CD20-, and CD43(MT1)+/-. A high proliferation rate 
reaching 80% of the neoplastic population was observed, as 
detected by Ki67/MIB1 immunoreactivity (Figure 3A and B). 
Over the next two weeks, the patient had ptosis and exophthal-
mos in the right eye. Slit-lamp biomicroscopy revealed 
Figure 1 (A and B) Anterior segment slit-lamp photograph of the left eye showing 
a pink-yellow colored mass infiltrating the bulbar conjunctiva in the lower fornix 
of the eyelid (arrow) and a corneal ulcer at the 9 o’clock position with perilimbal 
congestion and chemosis (arrow).
Figure 2 Diffuse proliferation of small atypical lymphoid cells, partly effacing the 
mucosal glands (hematoxylin and eosin, 40×). Figure 3 (A and B) CD3 and Ki67 immunoreactivity (ABC peroxidase, 40×).
Figure 3
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was followed carefully by the oncology service for staging 
that was classified as IVB. He was receiving a regimen of 
chemotherapy comprising cyclophosphamide 750 mg/mq, 
epidoxorubicin 50 mg/mq, vincristine 1.4 mg/mq, and pred-
nisone 50 mg/mq on days 1 and 5. Simultaneously, the patient 
underwent locoregional radiotherapy with a total of 20 Gy to 
the retro-orbital region. The patient died of an acute myocar-
dial infarction after the two cycles of chemotherapy.
diffuse congestion and marked chemosis involving the entire 
  epibulbar conjunctiva of the right eye (Figure 4A and B). 
Over a period of four weeks, there was rapid expansion of 
the tumor involving the right ocular adnexa, with ptosis, 
proptosis, and periorbital tissue infiltration (Figure 4C and D). 
Computed tomography of the maxillofacial region and abdo-
men demonstrated parenchymal infiltrations in the ethmoidal 
cells, periorbital region, and pancreas (Figure 5). The patient 
Figure 5 Computed tomography of the maxillofacial region showing parenchymatous infiltrations at the level of the ethmoidal cells, optic nerve, and the medial and anterior 
periorbital region (dotted line).
Note: Abdominal computed tomography demonstrated a lymphoid mass at the level of the head and body of the pancreas (arrows).
Figure 4 (A and B) Photographic documentation of ptosis and conjunctival chemosis involving the right eye. (C and D) Massive extension at the right ocular adnexa with 
ptosis, proptosis, and periorbital tissue infiltration.
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Discussion
Ocular involvement of T cell lymphoma may include orbital, 
conjunctival, eyelid, uveal, and vitreous localization.1 
Malignant ocular T cell lymphoma can be associated with 
systemic involvement.2–5 Despite a typical appearance, the 
differential diagnosis includes scleritis and several other 
benign tumors of the ocular surface, including squamous 
papilloma, pyogenic granuloma, and lymphangiectasis.4
There are two important aspects concerning this case 
report. Firstly, the initial manifestation of this tumor was 
at the lower fornix of the left conjunctiva that was easy 
accessible to diagnostic punch biopsy, which enabled early 
diagnosis of T cell lymphoma. Secondly, general examina-
tion showed systemic involvement with ethmoidal, maxillary 
and sphenoidal sinus masses, and pancreatic infiltration. An 
orbital component was also evident. Lymphoid tumors of 
the conjunctiva are associated with systemic lymphoma in 
about 31% of patients.4 They may not be symptomatic for 
many months or years.1–5 In this case, we could not identify 
the primary site of the lymphoid tumor because ocular 
involvement was found to be associated with extraocular 
systemic lymphomatous proliferation. T cell lymphoma of 
the conjunctiva as a primary manifestation of systemic cancer 
is an extremely rare entity. Punch conjunctival biopsy may 
be the first diagnostic pathway useful to initiate a search for 
systemic involvement of a malignant lymphoid tumor of the 
T cell variety.
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